{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:28:16Z","timestamp":1792236496858,"version":"4.4.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[1997,4,15]]},"abstract":"<jats:p>\n                    <jats:italic>Background<\/jats:italic>\n                    Cardiac myocyte sarcolemma contains both catecholamine and opioid peptide receptors (OPRs). Opioid peptides are coreleased with catecholamines from nerve terminals in the heart. We investigated whether OPR stimulation influences the effects of \u03b2-adrenergic receptor (\u03b2-AR) stimulation in the isolated, isovolumic rat heart and whether the mechanism of such an interaction involves both \u03b2-AR subtypes or an alteration in \u03b2-AR\u2013mediated increase in cAMP.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Methods and Results<\/jats:italic>\n                    Norepinephrine (NE, 10\n                    <jats:sup>\u22127<\/jats:sup>\n                    mol\/L) increased peak left ventricular systolic pressure (LVSP) and cAMP more than twofold compared with controls. The \u03b4-OPR agonist leucine-enkephalin (LE, 10\n                    <jats:sup>\u22128<\/jats:sup>\n                    mol\/L) markedly inhibited the \u03b2\n                    <jats:sub>1<\/jats:sub>\n                    -AR\u2013induced positive inotropic effect and increase in cAMP but alone had no effect on basal LVSP or basal cAMP levels. The OPR antagonist naloxone 10\n                    <jats:sup>\u22128<\/jats:sup>\n                    mol\/L added to LE+NE perfusate reversed the LE-induced decrease in cAMP and LVSP even though naloxone alone had no effect on LVSP and cAMP levels. LE could not counteract the twofold increase in LVSP produced by the nondegradable cAMP analog CPTcAMP 2.3\u00d710\n                    <jats:sup>\u22125<\/jats:sup>\n                    mol\/L or a high concentration of forskolin (10\n                    <jats:sup>\u22127<\/jats:sup>\n                    mol\/L) but did reverse the 173\u00b111.8% and 135\u00b113.6% increases in LVSP stimulated by 10\n                    <jats:sup>\u22128<\/jats:sup>\n                    and 0.5\u00d710\n                    <jats:sup>\u22128<\/jats:sup>\n                    mol\/L forskolin, respectively. LE inhibited cAMP production at all concentrations of forskolin (10\n                    <jats:sup>\u22127<\/jats:sup>\n                    , 10\n                    <jats:sup>\u22128<\/jats:sup>\n                    , and 0.5\u00d710\n                    <jats:sup>\u22128<\/jats:sup>\n                    mol\/L). Pertussis toxin (PTX) pretreatment abolished LE effects on \u03b2\n                    <jats:sub>1<\/jats:sub>\n                    -AR stimulation. Zinterol 10\n                    <jats:sup>\u22125<\/jats:sup>\n                    and 10\n                    <jats:sup>\u22126<\/jats:sup>\n                    mol\/L, a specific \u03b2\n                    <jats:sub>2<\/jats:sub>\n                    -AR agonist that elicits a cAMP-independent inotropic effect in rat heart, caused 225\u00b114% and 182\u00b15% increases in LVSP that could not be reversed by addition of LE.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusions<\/jats:italic>\n                    Potent, inhibitory \u201ccross talk\u201d between \u03b4-OPR and \u03b2\n                    <jats:sub>1<\/jats:sub>\n                    -AR signaling pathways occurs via a PTX-sensitive G\n                    <jats:sub>i\/o<\/jats:sub>\n                    protein involved in adenylyl cyclase inhibition in rat heart.\n                  <\/jats:p>","DOI":"10.1161\/01.cir.95.8.2122","type":"journal-article","created":{"date-parts":[[2012,6,11]],"date-time":"2012-06-11T20:41:02Z","timestamp":1339447262000},"page":"2122-2129","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":66,"title":["\u2018Cross Talk\u2019 Between Opioid Peptide and Adrenergic Receptor Signaling in Isolated Rat Heart"],"prefix":"10.1161","volume":"95","author":[{"given":"Salvatore","family":"Pepe","sequence":"first","affiliation":[{"name":"From the Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, Baltimore, Md (S.P., R.-P.X., E.G.L.), and the Department of Medical Biochemistry, Ohio State University, Columbus (C.H., R.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Ping","family":"Xiao","sequence":"additional","affiliation":[{"name":"From the Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, Baltimore, Md (S.P., R.-P.X., E.G.L.), and the Department of Medical Biochemistry, Ohio State University, Columbus (C.H., R.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Hohl","sequence":"additional","affiliation":[{"name":"From the Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, Baltimore, Md (S.P., R.-P.X., E.G.L.), and the Department of Medical Biochemistry, Ohio State University, Columbus (C.H., R.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Altschuld","sequence":"additional","affiliation":[{"name":"From the Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, Baltimore, Md (S.P., R.-P.X., E.G.L.), and the Department of Medical Biochemistry, Ohio State University, Columbus (C.H., R.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward G.","family":"Lakatta","sequence":"additional","affiliation":[{"name":"From the Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, Baltimore, Md (S.P., R.-P.X., E.G.L.), and the Department of Medical Biochemistry, Ohio State University, Columbus (C.H., R.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.23.040183.002545"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1994.1085"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1993.265.1.C212"},{"key":"e_1_3_2_4_2","first-page":"H1560","volume":"264","year":"1992","unstructured":"Springhorn JP, Claycomb WC. Translation of heart preproenkephalin mRNA and secretion of enkephalin peptides from cultured cardiac myocytes. Am J Physiol. 1992;264:H1560-H1566.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2580073"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.6.1960"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(89)90456-2"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(91)90086-2"},{"key":"e_1_3_2_9_2","first-page":"599","volume":"26","year":"1993","unstructured":"Ela C, Hasin Y, Eilam Y. Opioid effects on contractility, Ca2+-transients and intracellular pH in cultured cardiac myocytes. J Mol Cell Cardiol. 1993;26:599-613.","journal-title":"J Mol Cell Cardiol"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1993.1079"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.70.1.1309318"},{"key":"e_1_3_2_12_2","first-page":"H1671","volume":"261","year":"1991","unstructured":"Ventura C, Capogrossi MC, Spurgeon H, Lakatta EG. \u03ba Opioid peptide receptor stimulation increases cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes. Am J Physiol. 1991;261:H1671-H1674.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","unstructured":"Cl\u00f4 C Pignatti C Tantini B Ventura C Bernardi P. Opioids regulate cyclic nucleotide levels in cultured heart cells (HC). J Mol Cell Cardiol. 1984;16(suppl 2):7. Abstract.","DOI":"10.1016\/S0022-2828(84)80378-8"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(87)90469-1"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(78)91107-1"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)32287-1"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.92.6.1612"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.69.5.1682066"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.73.2.8101141"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117559"},{"key":"e_1_3_2_21_2","unstructured":"Xiao R-P Lakatta EG. Different mechanisms mediate actions of \u03b21- and \u03b22-adrenergic receptor stimulation on canine cardiac L-type Ca2+ current. Circulation. 1995;92(suppl I):I-432. Abstract."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0026-895X(25)08543-8","volume":"47","year":"1995","unstructured":"Xiao R-P, Ji X, Lakatta EG. Functional coupling of the \u03b22-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol. 1995;47:322-329.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2460687"},{"key":"e_1_3_2_24_2","unstructured":"Xiao R-P Pepe S Capogrossi MC Spurgeon H Lakatta EG. Opioid peptide receptor stimulation reverses \u03b2-adrenergic effects in rat heart cells. Am J Physiol. In press."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)88841-X"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1981.tb10434.x"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.56.070187.003151"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0026-895X(25)13643-2","volume":"43","year":"1993","unstructured":"Law PY, Loh HH. \u03b4-Opioid-receptor activates cAMP phosphodiesterase activities in neuroblastoma\u00d7glioma NG108-15 hybrid cells. Mol Pharmacol. 1993;43:684-693.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2670391"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0026-895X(25)10216-2","volume":"45","year":"1994","unstructured":"Prather PL, Loh HH, Law PY. Interaction of \u03b4-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins. Mol Pharmacol. 1994;45:997-1003.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(93)90314-H"},{"key":"e_1_3_2_32_2","first-page":"19","volume":"158","year":"1996","unstructured":"Kaumann AJ, Sanders L, Lynham JA, Bartel S, Kushel M, Kar-czewski P, Krause E-G. \u03b22-Adrenoceptor activation by zinterol causes protein phosphorylation, contractile effects and relaxant effects through a cAMP pathway in human atrium. Mol Cell Biochem. 1996;158:19-26.","journal-title":"Mol Cell Biochem"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.14-04-01920.1994"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/341197a0"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.66.4.2317891"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1846707"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.11.5297"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.8.3365"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1988.tb02945.x"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.56.5.2581720"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1990.tb12734.x"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/27.11.1948"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)50062-X"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0026-895X(25)10581-6","volume":"45","year":"1994","unstructured":"Hilal-Dandan R, Merck DT, Lujan JP, Brunton LL. Coupling of the endothelin type A receptor to multiple responses in adult rat cardiac myocytes. Mol Pharmacol. 1994;45:1183-1190.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199402000-00025"},{"key":"e_1_3_2_46_2","first-page":"115","volume":"58","year":"1996","unstructured":"Jones LG. Inhibition of cyclic AMP accumulation by endothelin is pertussis toxin sensitive and Ca2+ independent in isolated adult feline cardiac myocytes. Life Sci. 1996;58:115-123.","journal-title":"Life Sci"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.57.4.2412720"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1990.tb14165.x"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0033-0620(89)90015-7"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508103330607"},{"key":"e_1_3_2_51_2","first-page":"A520","volume":"27","year":"1995","unstructured":"Kita H, Miura T, Tsuchida A, Sakamoto J, Imura O. Roles of opioid receptor and protein kinase C in suppression of reperfusion arrhythmia by preconditioning. J Mol Cell Cardiol. 1995;27:A520. Abstract.","journal-title":"J Mol Cell Cardiol"},{"key":"e_1_3_2_52_2","first-page":"A187","volume":"28","year":"1996","unstructured":"Miki T, Downey JM. Opioid receptors participate in ischemic preconditioning in rabbits. J Mol Cell Cardiol. 1996;28:A187. Abstract.","journal-title":"J Mol Cell Cardiol"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(88)81107-0"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(91)90221-V"},{"key":"e_1_3_2_55_2","first-page":"H912","volume":"267","year":"1994","unstructured":"Imai N, Kashiki M, Woolf PD, Liang C-S. Comparison of cardiovascular effects of \u03bc- and \u03b4-OPR antagonists in dogs with congestive heart failure. Am J Physiol. 1994;267:H912-H917.","journal-title":"Am J Physiol"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.95.8.2122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T16:51:14Z","timestamp":1743353474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.95.8.2122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4,15]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1997,4,15]]}},"alternative-id":["10.1161\/01.CIR.95.8.2122"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.95.8.2122","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,4,15]]},"assertion":[{"value":"1996-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-11-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-04-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}